Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health

Who May Qualify: - Adult, 18- 65 years old. - Had history of acute coronary syndrome (ACS) - Clinically stable - Self-reported eating window of at least 12 h per day. Who Should NOT Join This Trial: - Severe obesity (body mass index ≥40 kg m-2). - Unstable weight in the past three months (gain or lose more than 4 kg of weight). - Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity. - Any medications or supplements known to change sleep, circadian rhythms, or metabolism. - Pregnant or lactating women. - Perform overnight shift work more than one day/week on average. - Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months). - Active use of tobacco or illicit drug or history of treatment for alcohol abuse. - Type I diabetes or diabetic, treated with insulin. - Use of anti-obesity drugs or other drugs affecting body weight. - Currently enrolled in weight loss or management programme, including surgical intervention. - Severe kidney failure (glomerular filtration rate (GFR) \<30 mL/min). - Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement. - Malignancy undergoing active treatment. - Had gastrointestinal surgery or impaired nutrient absorption. - Travelled more than two time zones away two months prior to enrolling in the trial or will travel more than two time zones away during the study period. - Concurrent participation in other interventional studies Always talk to your doctor about whether this trial is right for you.